Registry and biorepository for pulmonary imaging
Quantitative Pulmonary Imaging Registry & Biorepository
This study is trying to collect images and samples from people using new lung imaging techniques to see how they can help us understand and improve lung health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Kansas Medical Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Kansas City, Kansas) |
| Trial ID | NCT05530408 on ClinicalTrials.gov |
What this trial studies
This project aims to create a registry and biorepository of images and biological samples from individuals undergoing innovative pulmonary imaging techniques. The focus is on quantitative imaging methods, particularly quantitative computed tomography (qCT) and advanced MRI techniques, to enhance the understanding of lung health. By collecting and analyzing these data, the study seeks to identify clinical applications for these imaging methods and their physiological significance, ultimately facilitating the adoption of quantitative pulmonary imaging in clinical settings.
Who should consider this trial
Good fit: Ideal candidates are individuals enrolled in research studies at the University of Kansas Medical Center involving Pulmonary MRI and/or Pulmonary CT.
Not a fit: Patients who decline to participate in the study will not benefit from the findings.
Why it matters
Potential benefit: If successful, this initiative could lead to improved diagnostic and monitoring techniques for patients with pulmonary diseases.
How similar studies have performed: While the approach of using advanced imaging techniques is gaining traction, the specific combination of qCT and MRI in this registry context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The participant is enrolling/has enrolled in a research study at the University of Kansas Medical Center that involves Pulmonary MRI and/or Pulmonary CT. Exclusion Criteria: * The participant declines to participate.
Where this trial is running
Kansas City, Kansas
- University of Kansas Medical Center — Kansas City, Kansas, United States (Recruiting)
Study contacts
- Principal investigator: Peter J Niedbalski, PhD — Research Assistant Professor
- Study coordinator: Cristal Monge
- Email: chernandez@kumc.edu
- Phone: 9135882473
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.